Göm menyn

Publications for Anita Kullman

Co-author map based on Web of Sciences articles 2007-

Journal Articles

Maria Nord, Anita Kullman, Ulf Hannestad and Nil Dizdar
  Is Levodopa Pharmacokinetics in Patients with Parkinson’s Disease Depending on Gastric Emptying?
  Advances in Parkinsons Disease, 2017, 06(01), .
   Fulltext  PDF  

Maria Nord, Peter Zsigmond, Anita Kullman and Nil Dizdar-Segrell
  Levodopa Pharmacokinetics in Brain after Both Oral and Intravenous Levodopa in One Patient with Advanced Parkinson’s Disease
  Advances in Parkinsons Disease, 2017, 6(2), 52-66.
   Fulltext  PDF  

Peter Zsigmond, Maria Nord, Anita Kullman, Elin Diczfalusy, Karin Wårdell and Nil Dizdar
  Neurotransmitter levels in basal ganglia during levodopa and deep brain stimulation treatment in Parkinson’s disease
  Neurology and Clinical Neuroscience, 2014, 2(5), 149-155.

Nil Dizdar, Peter Zsigmond, Anita Kullman and Dzeneta Nezirevic
  Letter: Untitled
  Journal of Neuroscience Methods, 2013, 212(2), 363-363.

Peter Zsigmond, Dzeneta Nezirevic Dernroth, Anita Kullman, Lars-Erik Augustinsson and Nil Dizdar
  Stereptactic microdialysis of the basal ganglia in Parkinson's disease
  Journal of Neuroscience Methods, 2012, 207(1), 17-22.
 Web of Science® Times Cited: 11

Elin Diczfalusy, Peter Zsigmond, Nil Dizdar, Anita Kullman, Dan Loyd and Karin Wårdell
  A model for simulation and patient-specific visualization of the tissue volume of influence during brain microdialysis
  Medical and Biological Engineering and Computing, 2011, 49(12), 1459-1469.
   Fulltext  PDF  
 Web of Science® Times Cited: 8

Maria Nord, Peter Zsigmond, Anita Kullman, Kerstin Årstrand and Nil Dizdar
  The Effect of Peripheral Enzyme Inhibitors on Levodopa Concentrations in Blood and CSF
  Movement Disorders, 2010, 25(3), 363-367.
 Web of Science® Times Cited: 4

Catarina Trager, Asa Vernby, Anita Kullman, Ingrid Ora, Per Kogner and Bertil Kågedal
  mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis
  International Journal of Cancer, 2008, 123(12), 2849-2855.
 Web of Science® Times Cited: 20

Kerstin Årstrand, Anita Kullman, R Andersson, T Rasmuson and Bertil Kågedal
  Improved method for analysis of cysteinyldopa in human serum
  Scandinavian Journal of Clinical and Laboratory Investigation, 2004, 64(6), 559-564.
 Web of Science® Times Cited: 2

Bertil Kågedal, Anita Kullman, Liselotte Lenner, Catarina Träger, Per Kogner and Malin Farnebäck
  Pterin-dependent tyrosine hydroxylase mRNA is not expressed in human melanocytes or melanoma cells
  Pigment Cell Research, 2004, 17(4), 346-351.
 Web of Science® Times Cited: 6

Chatarina Träger, Per Kogner, Magnus Lindskog, Frida Ponthan, Anita Kullman and Bertil Kågedal
  Quantitative analysis of tyrosine hydroxylase mrna for sensitive detection of neuroblastoma cells in blood and bone marrow
  Clinical Chemistry, 2003, 49(1), 104-112.
 Web of Science® Times Cited: 40

Nil Dizdar (Segrell), Anita Kullman and Bertil Kågedal
  Comparison of N-acetylcysteine and l-2-oxothiazolidine-4-carboxylate as cysteine deliverers and glutathione precursors in human malignant melanoma transplants in mice
  Cancer chemotherapy and pharmacology, 2000, 45(3), 192-198.
 Web of Science® Times Cited: 5

Nil Dizdar (Segrell), Anita Kullman, Björn Norlander, Jan-Edvin Olsson and Bertil Kågedal
  Human pharmacokinetics of L-3,4-dihydroxyphenylalanine studied with microdialysis
  Clinical Chemistry, 1999, 45(10), 1813-1820.

Nil Dizdar (Segrell), Ann-Kathrine Granerus, Ulf Hannestad, Anita Kullman, Å. Ljungdahl, Jan-Edvin Olsson and Bertil Kågedal
  L-dopa pharmacokinetics studied with microdialysis in patients with Parkinson's disease and a history of malignant melanoma
  Acta neurologica Scandinavica, 1999, 100(4), 231-237.

Nil Dizdar (Segrell), Anita Kullman, Bertil Kågedal and Kerstin Årstrand
  Effects on interstitial glutathione, cysteine and 5-S-cysteinyldopa of buthionine sulphoximine in human melanoma transplants
  Melanoma research, 1997, 7(4), 322.-328.

Conference Articles

Elin Diczfalusy, Nil Dizdar, Peter Zsigmond, Anita Kullman, Dan Loyd and Karin Wårdell
  Simulations and visualizations for interpretation of brain microdialysis data during deep brain stimulation
  IEEE Engineering in Medicine and Biology Society (EMBC), 2012, 2012.

 Web of Science® Times Cited: 2

Elin Diczfalusy, Mattias Åström, Nil Didzar, Anita Kullman, Peter Zsigmond and Karin Wårdell
  A finite element model for biochemical monitoring in the brain during deep brain stimulation (poster)
  World Congress of Neurotechnology, Rome 11-14 Oct. 2010, 2010.

Elin Diczfalusy, Mattias Åström, Nil Dizdar, Anita Kullman, Peter Zsigmond and Karin Wårdell
  A Finite Model for Biochemical Monitoring in the Brain during Deep Brain Stimulation (oral)
  Medicinteknikdagarna 2010, 6‐7 oktober, Umeå, 2010.

Elin Diczfalusy, Nil Didzar, Anita Kullman, Mattias Åström, Peter Zsigmond and Karin Wårdell
  Biochemical monitoring and simulation of the electric field during deep brain stimulation (oral)
  XIX Congress of the European Stereotactic and functional neurosurgery (ESSFN), Athens 22-25 Sept. 2010, 2010.

Peter Zsigmond, Mattias Åström, Elin Diczfalusy, Anita Kullman, Nil Dizdar and Karin Wårdell
  Biochemical Monitoring and Simulation of the Electric Field during Deep Brain Stimulation
  Medicinteknikdagarna 2009, 28-29 September, Västerås, 2009.


Responsible for this page: Peter Berkesand
Last updated: 2017-02-21